Landfear Scott M
Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon 97239, USA.
Adv Exp Med Biol. 2008;625:22-32. doi: 10.1007/978-0-387-77570-8_3.
Kinetoplastid protozoa express hundreds of membrane transport proteins that allow them to take up nutrients, establish ion gradients, efflux metabolites, translocate compounds from one intracellular compartment to another, and take up or export drugs. The combination of molecular cloning, genetic approaches, and the completed genome projects for Trypanosoma brucei, Leishmania major, and Trypanosoma cruzi have allowed detailed functional analysis of various transporters and predictions about the likely functions of others. Thus many opportunities exist to define the biological and pharmacological properties of parasite transporters whose genes were often difficult to identify in the pregenomic era. A subset of these transporters that are essential for parasite viability could serve as targets for novel drug therapies by identifying compounds that interfere with their uptake functions. Other permeases provide routes for uptake of selectively cytotoxic compounds and can thus be useful for delivery of drugs. Drug resistance may develop in strains where such drug uptake transporters are nonfunctional or in parasites that over-express other permeases that export a drug. A summary of recent work on Leishmania transporters for glucose and for purines is provided as an example of permeases that are being studied in molecular detail.
动质体原生动物表达数百种膜转运蛋白,这些蛋白使它们能够摄取营养物质、建立离子梯度、排出代谢产物、将化合物从一个细胞内区室转运到另一个区室,以及摄取或排出药物。分子克隆、遗传学方法以及布氏锥虫、硕大利什曼原虫和克氏锥虫完整的基因组计划相结合,使得对各种转运蛋白进行详细的功能分析以及对其他转运蛋白可能的功能进行预测成为可能。因此,有很多机会来确定寄生虫转运蛋白的生物学和药理学特性,而这些转运蛋白的基因在基因组时代之前往往很难鉴定。这些对寄生虫生存至关重要的转运蛋白的一个子集,通过鉴定干扰其摄取功能的化合物,可作为新型药物疗法 的靶点。其他通透酶为选择性细胞毒性化合物的摄取提供途径,因此可用于药物递送。在药物摄取转运蛋白无功能的菌株中,或者在过度表达其他排出药物的通透酶的寄生虫中,可能会产生耐药性。本文以对利什曼原虫葡萄糖和嘌呤转运蛋白的最新研究为例,对正在进行分子细节研究的通透酶进行了总结。